Ali Behbahani

Dr. Behbahani is a Partner at NEA. He specializes in investments in the biopharmaceutical, medical device, specialty pharmaceutical and health care services sectors.

Before joining NEA, he was an intern and business development consultant at The Medicines Company, a specialty pharmaceutical company developing acute care cardiovascular products. Dr. Behbahani previously held positions as a Venture Associate at Morgan Stanley Venture Partners and as a Healthcare Investment Banking Analyst at Lehman Brothers. He also conducted basic science research in the fields of viral fusion inhibition and structural proteomics at the National Institutes of Health and at Duke University.

Dr. Bahbahani graduated summa cum laude and received his bachelor’s degrees with distinction in Biomedical Engineering, Electrical Engineering and Chemistry from Duke University. He concurrently earned his M.D. from the University of Pennsylvania School of Medicine and his M.B.A. from the University of Pennsylvania Wharton School, where he graduated with Honors and was a Palmer Scholar.